Podcast: Developing non-invasive therapies for glioblastoma
While researchers and drug developers have made several efforts to develop effective treatments for glioblastoma (GBM), the standard of care…
All articles by Annabel Kartal Allen
Annabel Kartal Allen
Annabel Kartal-Allen is a reporter for Clinical Trials Arena, Pharmaceutical Technology and Medical Device Network based in London, UK. Annabel holds interests in oncology, neurology and metabolic diseases. She has previous experience reporting for both the pharmaceutical and nutraceutical industries, and holds a BSc in Biology from the University of Sussex. Contact Annabel
-
-
Agentic AI trust gap slowing healthcare provider adoption, survey reveals
A new survey from digital healthcare security specialist Imprivata has revealed that, while artificial intelligence (AI) is now becoming commonplace…
-
Apollo rumoured to be eyeing $20bn takeover of J&J’s orthopaedics business
Alternative asset management company Apollo Global Management is reportedly in talks to acquire Johnson & Johnson’s (J&J) orthopaedics unit through…
-
Axogen deepens nerve repair portfolio through $200m BioCircuit takeover
Florida-based medtech company, Axogen has agreed to acquire BioCircuit Technologies for $200m, further bolstering its presence in the surgical peripheral…
-
FDA rallies HRT manufacturers amid US-wide estradiol patch shortage
The US Food and Drug Administration (FDA) has started working with six drug-device manufacturers involved in the production of transdermal…
-
Vara nets first CE mark for autonomous AI breast cancer screening tool
Vara has secured a European CE mark for an autonomous, artificial intelligence (AI)-powered breast cancer screening triage tool – marking…
-
Trump expected to nominate Heidi Overton as new FDA commissioner
US President Donald Trump is expected to put forward Heidi Overton as his choice for the next commissioner of the…
-
Health tech’s role in obesity to expand beyond a ‘nice-to-have’
In recent years, there has been a sharp focus on treating obesity and its associated comorbidities, as the World Health…
-
Profusa vies for potential G3 Vision Labs acquisition
Digital health specialist Profusa has inked an option agreement to acquire G3 Vision Labs and its subsidiaries, giving the company…
-
NICE greenlights first non-invasive endometriosis diagnostic tools
The UK’s National Institute for Health and Care Excellence (NICE) has recommended two non-invasive endometriosis diagnostic tests for use across…